Colonization Factors in Enterotoxigenic Escherichia Coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas

Overview

Journal Am J Trop Med Hyg

Specialty Tropical Medicine

Date 2017 Jan 13

PMID 28077742

Citations 12

Authors

Vineetkumar B Kharat

Makhdum Ahmed

Zhi-Dong Jiang

Mark S Riddle

Herbert L DuPont

Affiliations

Soon will be listed here.

Abstract

Enterotoxigenic Escherichia coli (ETEC) can be attributed to around 200 million diarrheal episodes and 380,000 deaths in the developing regions. Travelers' diarrhea occurs in 15-40% of travelers to developing regions with ETEC being the most important etiologic agent. This study aims to describe the distribution of enterotoxins and colonization factor (CF) profiles of ETEC isolates from stool samples of adult travelers acquiring diarrhea in Mexico, Guatemala, and India and a group of children with acute diarrhea in Houston, TX, between 2007 and 2012. The heat-labile/heat-stable (LT/ST) enterotoxins and CFs from 252 patients were determined using polymerase chain reaction assay. Among the 252 ETEC isolates, 15% were LT-only, 58% were ST-only, and 28% produced both LT and ST. The distribution of LT-only (12-15%) and ST-only (55-56%) isolates was similar between Latin American and Indian sites. The most prevalent CF was CS21, expressed in 65% of the isolates followed by CS6 (25%) and CS3 (17%). Among the international travelers, 64% of the ETEC isolates expressed CS21. CS21 was expressed in 46% of isolates from Latin America compared with 96% of isolates from India (P < 0.0001). CS21 was expressed in 85% isolates from Houston children. CS21 was increasingly found in ST-only (P = 0.003) and ST/LT (P = 0.026) ETEC compared with LT-only ETEC. High frequency of finding CS21 among recent isolates of ETEC over a wide geographic distribution warrants additional studies on this CF. Highly conserved CS21 is an important target for potential multivalent ETEC vaccines.

Citing Articles

Genome Sequencing and Assembly of Enterotoxigenic E9034A: Role of LngA, CstH, and FliC in Intestinal Cell Colonization and the Release of the Proinflammatory Cytokine IL-8.

Rodriguez-Martinez R, Ochoa S, Valle-Rios R, Jaimes-Ortega G, Hernandez-Castro R, Mancilla-Rojano J Microorganisms. 2025; 13(2).

PMID: 40005742 PMC: 11858209. DOI: 10.3390/microorganisms13020374.

A Polyvalent Adhesin-Toxoid Multiepitope-Fusion-Antigen-Induced Functional Antibodies against Five Enterotoxigenic Adhesins (CS7, CS12, CS14, CS17, and CS21) but Not Enterotoxins (LT and STa).

Li S, Seo H, Upadhyay I, Zhang W Microorganisms. 2023; 11(10).

PMID: 37894131 PMC: 10608864. DOI: 10.3390/microorganisms11102473.

Polyvalent Protein Adhesin MEFA-II Induces Functional Antibodies against Enterotoxigenic Escherichia coli (ETEC) Adhesins CS7, CS12, CS14, CS17, and CS21 and Heat-Stable Toxin (STa).

Upadhyay I, Parvej S, Li S, Lauder K, Shen Y, Zhang W Appl Environ Microbiol. 2023; 89(6):e0068323.

PMID: 37212687 PMC: 10304760. DOI: 10.1128/aem.00683-23.

Colonization with extended-spectrum beta-lactamase-producing Escherichia coli and traveler's diarrhea attack rates among travelers to India: a systematic review and meta-analysis.

Muzembo B, Kitahara K, Ohno A, Okamoto K, Miyoshi S Trop Dis Travel Med Vaccines. 2022; 8(1):22.

PMID: 36180932 PMC: 9525155. DOI: 10.1186/s40794-022-00179-1.

The role of CFA/I in adherence and toxin delivery by ETEC expressing multiple colonization factors in the human enteroid model.

Smith E, Grassel C, Papadimas A, Foulke-Abel J, Barry E PLoS Negl Trop Dis. 2022; 16(7):e0010638.

PMID: 35881640 PMC: 9355178. DOI: 10.1371/journal.pntd.0010638.

References

Nicklasson M, Sjoling A, von Mentzer A, Qadri F, Svennerholm A . Expression of colonization factor CS5 of enterotoxigenic Escherichia coli (ETEC) is enhanced in vivo and by the bile component Na glycocholate hydrate. PLoS One. 2012; 7(4):e35827. PMC: 3342736. DOI: 10.1371/journal.pone.0035827. View

Sack D, Shimko J, Torres O, Bourgeois A, Francia D, Gustafsson B . Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico. Vaccine. 2007; 25(22):4392-400. DOI: 10.1016/j.vaccine.2007.03.034. View

Qadri F, Svennerholm A, Faruque A, Sack R . Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev. 2005; 18(3):465-83. PMC: 1195967. DOI: 10.1128/CMR.18.3.465-483.2005. View

Tacket C, Losonsky G, Link H, Hoang Y, Guesry P, HILPERT H . Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med. 1988; 318(19):1240-3. DOI: 10.1056/NEJM198805123181904. View

Louis Bourgeois A, Wierzba T, Walker R . Status of vaccine research and development for enterotoxigenic Escherichia coli. Vaccine. 2016; 34(26):2880-2886. DOI: 10.1016/j.vaccine.2016.02.076. View

Frech S, DuPont H, Louis Bourgeois A, McKenzie R, Belkind-Gerson J, Figueroa J . Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008; 371(9629):2019-25. DOI: 10.1016/S0140-6736(08)60839-9. View

Holmgren J, Bourgeois L, Carlin N, Clements J, Gustafsson B, Lundgren A . Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen,.... Vaccine. 2013; 31(20):2457-64. DOI: 10.1016/j.vaccine.2013.03.027. View

Guevara C, Luiz W, Sierra A, Cruz C, Qadri F, Kaushik R . Enterotoxigenic Escherichia coli CS21 pilus contributes to adhesion to intestinal cells and to pathogenesis under in vivo conditions. Microbiology (Reading). 2013; 159(Pt 8):1725-1735. PMC: 3749052. DOI: 10.1099/mic.0.065532-0. View

Rao M, Wierzba T, Savarino S, Abu-Elyazeed R, El-Ghoreb N, Hall E . Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea. J Infect Dis. 2005; 191(4):562-70. DOI: 10.1086/427662. View

10.

Darsley M, Chakraborty S, DeNearing B, Sack D, Feller A, Buchwaldt C . The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease. Clin Vaccine Immunol. 2012; 19(12):1921-31. PMC: 3535858. DOI: 10.1128/CVI.00364-12. View

11.

Cruz-Cordova A, Espinosa-Mazariego K, Ochoa S, Saldana Z, Rodea G, Cazares-Dominguez V . CS21 positive multidrug-resistant ETEC clinical isolates from children with diarrhea are associated with self-aggregation, and adherence. Front Microbiol. 2015; 5:709. PMC: 4297921. DOI: 10.3389/fmicb.2014.00709. View

12.

Rudin A, OLBE L, Svennerholm A . Monoclonal antibodies against fimbrial subunits of colonization factor antigen I (CFA/I) inhibit binding to human enterocytes and protect against enterotoxigenic Escherichia coli expressing heterologous colonization factors. Microb Pathog. 1996; 21(1):35-45. DOI: 10.1006/mpat.1996.0040. View

13.

Steffen R, Hill D, DuPont H . Traveler's diarrhea: a clinical review. JAMA. 2015; 313(1):71-80. DOI: 10.1001/jama.2014.17006. View

14.

Freedman D, Tacket C, Delehanty A, Maneval D, Nataro J, Crabb J . Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J Infect Dis. 1998; 177(3):662-7. DOI: 10.1086/514227. View

15.

Debnath A, Wajima T, Sabui S, Hamabata T, Ramamurthy T, Chatterjee N . Two specific amino acid variations in colonization factor CS6 subtypes of enterotoxigenic Escherichia coli results in differential binding and pathogenicity. Microbiology (Reading). 2015; 161(Pt 4):865-74. DOI: 10.1099/mic.0.000038. View

16.

Rivera F, Medina A, Aldasoro E, Sangil A, Gascon J, Ochoa T . Genotypic characterization of enterotoxigenic Escherichia coli strains causing traveler's diarrhea. J Clin Microbiol. 2012; 51(2):633-5. PMC: 3553866. DOI: 10.1128/JCM.02572-12. View

17.

Steffen R, Castelli F, Nothdurft H, Rombo L, Jane Zuckerman N . Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea. J Travel Med. 2005; 12(2):102-7. DOI: 10.2310/7060.2005.12207. View

18.

Jiang Z, Lowe B, Verenkar M, Ashley D, Steffen R, Tornieporth N . Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis. 2002; 185(4):497-502. DOI: 10.1086/338834. View

19.

Wenneras C, Erling V . Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world. J Health Popul Nutr. 2005; 22(4):370-82. View

20.

Torres O, Gonzalez W, Lemus O, Pratdesaba R, Matute J, Wiklund G . Toxins and virulence factors of enterotoxigenic Escherichia coli associated with strains isolated from indigenous children and international visitors to a rural community in Guatemala. Epidemiol Infect. 2014; 143(8):1662-71. PMC: 4416357. DOI: 10.1017/S0950268814002295. View